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Transferable Resistance to Carbenicillin and
Gentamicin in Pseudomonas aeruginosa
A. J. VAN RENSBURG
SUMMARY
Antibiograms on 482 routine isolates of Pseudomonas
aeruginosa yielded 64 (13,3%) carbenicillin-resistant
strains. In 40 of these strains resistance could be ascribed
to R factors. R factors accounted for resistance in 3 out
of 11 gentamicin-resistant strains. The significance of
resistance in Ps. aeruginosa is discussed.
S. Afr. Med. J., 48, 1185 (1974).
Gentamicin' and carbenicillin' are the drugs of choice
in the treatment of infection with Pseudomonas aemginosa.
However, this regimen of treatment has been accompanied
by the emergenc:: of drug resistance, particularly to
carbenicillin.'" Since the establishment of intensive care
units at the Bloemfontein National and Pelonomi Hospitals
we have noted an exceptional increase in the number of
Ps. aeruginosa strains isolated, as well as in its incidence
of resistance to gentamicin and carbenicillin.
This article reports on the occurrence of transmissible
drug resistance in Ps. aeruginosa strains, isolated in our
laboratory.
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MATERIALS AND MEmODS
Antibiotic Sensitivity Tests
Mast sensitivity discs were used to screen isolates of
Pseudomonas aemginosa for resistance to carbenicillin
and gentamicin. Resistance was confirmed by plating on
MacCcnkey agar containing the antibiotics at a concen-
tration of 1 000 ,ugjml for carbenicillin or 25 !-'g/ml for
gentamicin.
Minimum inhibitory concentrations (MIC) of the anti-
biotics were determined by spotting small drops (0,1 ml)
of diluted cultures (ID' bacteriajml) on Welco sensitivity
test agar plates containing doubling dilutions of carbeni-
cillin or gentamicin. The MIC was taken as the lowest
concentration of antibiotic that prevented growth.
Transfer of Carbenicillin and Gentamicin Resistance
Transfer of R factors was done as previously described.'"
The recipient was Escherichia coli Kl2 strain J53."
RESULTS
Carbenicillin Resistance in Pseudomonas aernginosa
Out of 482 routine isolates of Ps. aeruginosa 64 (13,3 %)
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Gentamicin Resistance in Pseudomonas aeruginosa
TABLE I. ANTIBIOTIC RESISTANCE DETERMINED BY
R FACTORS
Am = ampicillin, Ca = carbenicillin, Cm = chloramphenicol, Gm =
gentamicin, Km = kanamycin, Su = sulphonamide, Srn = streptomycin,
le = tetracyclint::.
of resistance markers to carbenicillin, ampiciJin, kana-
mycin and tetracycline. One of these R factors (RP-638)
was examined in further detail."
levels of resistance in our isolates, with minimum inhibitory
concentrations of 2500 Ilg/ml or more.
Inadequate dosage of carbenicillin is a potent method
for the selection of resistant mutants. These strains,
however, have been isolated from the intensive care
units where carbenicillin is only used when indicated by
microbiological reports. This can thus be excluded as a
cause for the emergence of resistant strains. It is known
that treatment with penicillins may result in the appearance
of carbenicillin resistance and the common use of ampi-
cillin probably contributes to this problem. A further
poss:bility is the transmission of R factors from resistant
E. coli and Proteus strains to Pseudomonas aeruginosa.
That such transfer does occur in vivo has been adequately
demonstrated." We have, however, shown that the
Pseudomonas R factors isolated by us are unique for
this species,' which argues against this hypothesis.
Problems are encountered in achieving high enough
concentrations of carbenicillin in lesions such as burns
and respiratory tract infections. These areas provide ideal
circumstances for the selection of resistant mutants and
the sole u~e of carbenicillin in the treatment of such
infections by Ps. aeruginosa is contra-indicated. In our
study only 2,3 % of the Ps. aeruginosa strains were
resistant to gentamicin (MIC 25 Ilg/ml). In view of the
synergy reported for combined gentamicin and carbeni-
cillin therapy," a combination of these two drugs may be
recommended in the treatment of all Pseudomonas
infections.








Am, Ca, Sm ...
Su, Cm, Ca, Am, Sm, Km, Te...
Am, Ca, Su, Sm, Cm
Am, Ca, Sm, Cm, Te
Am, Ca, Km, Te
Gm, Km
Ilg/ml). In 40 strains (62,5%) this resistance was transferred
to the E. coli recipient. Different resistant markers were
transferred simultaneously with carbenicillin resistance
(Table I). In 17 isolates markers for ampicillin, carbeni-
cillin, kanamycin and tetracycline resistance were located
on the same R factor, while 11 strains showed grouping
Eleven (2,3~~) strains were resistant to gentamicin at
a MIC of 25 fig/ml. Three of these strains possessed R
factors which determined resi,tance to gentamicin and
kanamycin.




Activity of carbenicillin against Pseudomonas aeruginosa
is low, MIC: 32 - 64 fig/ml, compared with values of 2 - 4
fig/ml for Escherichia coli and Proteus mirabilis. 10 How-
ever, toxicity and poor in vivo activity of other drugs
make carbenicillin an important antibiotic in the treat-
ment of infections by Ps. aeruginosa. Marked increases in
levels of carbenicillin resistance in Ps. aeruginosa were
described by Lowbury et al.3 We now report even higher
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